Академический Документы
Профессиональный Документы
Культура Документы
Saumitra Rahatekar
(848) 248 9998
Agenda
✤ CA/WA/CO/AZ calling
✤ Market for consultancy services
✤ Stimulus ’09
CA Snippets
✤ 20 % NIH funding in ’07 $3.5 Institution Biomedical Spinoffs
vs 20 in South CA Caltech 24
UC Davis 18
UC Los Angeles 18
✤ $4.5 billion VC funding in ‘07s The Salk Institute 16
USC 16
✤ Elementary Institute of Science
✤ Bayer’s Making Science Make Sense
✤ Eugene and Ruth Roberts Summer
✤ Biogen Idec Community Lab student academy
✤ Biotech Partners ✤ Genentech Foundation
Medical
Devices & CU
Research
Medical
Devices &
Pharma
✤ Recent government investments total
$800 million, UC Denver $275
million et.al
WA Snippets
✤ Puget Sound region had revenues of Medical
Healthcare and
Biotechnology
$4.8 billion in 2007 which is 70% of Device R & D
(Seattle,Bothel
total WA’s Life Science revenue l,Redmond)
Medical
$7.5 billion revenue from AZ
Device and
✤ Hospitals
Bio/Pharma sector
✤ Critical Path Initiative is based out of Research,
Testing
Phoenix, AZ Medical Labs
Research,
Testing,
AZ Pharma/Bio jobs are growing at
Medical Labs
✤
18 % for last 5 years
AZ snippets
Company Location Medicis Pharma Scottsdale
Abraxisbio Phoenix Medistem Inc Chandler
Amplimed Scottsdale Regenesis Biomedical Scottsdale
Apthera Scottsdale
Restorative Bio Chandler
Capstonehex Tucson
Rowpar Pharma Scottsdale
Gaasanalytical Scottsdale
Semafore Pharma Scottsdale
Genbiopro Tucson
Silamed Phoenix
HTgenomics Tucson
Vaxx Inc Tucson
Imarx Prescott
Ventana Medical System Oro Valley
Imulan Biotherapeutics Tucson
Virionics Corp Scottsdale
InNexus Biotechnology Scottsdale
Yaso Biotechnology Phoenix
Konec Inc. Tucson
Immuneregen Phoenix Zila Pharmaceuticals Phoenix
Monitoring
Data
✤ Medical writing is the fastest growing Management
service $700 million in ’08 growing at 15%
p.a for last 5 years while overall CRO market Drug Supply
is $21 billion with 12% growth in ’08 management
Site
Management
Reg Affairs
ASR - Analyte Specific reagents
(building blocks of lab developed
tests)
✤ Development & Approval of
IVDMIA - Invitro diagnostics
Therapeutics FDA (via IND,
Multivariate Indexed assays
LDT - Lab Developed tests
NDA/BLA)CMS - Centers of Medicare and
Medicaid services
✤ FDA (part 312, GCP) / HHS,OCR
CLIA - Clinical Labs law (HIPAA) / the states (sometimes)
✤ Dx FDA for Clearance and approvals
of test kits, ASRs, IVDMIAs, (via 510k,
For Medicaid most of the decisions
are made at the state level ✤ Challenges to the industry Validation
PMA) CMS regulates the labs that
HHS - Health and Human Services
of Biomarkers / Uncertainty on
create LDTs ( under CLIA)
OCR - Offices of civil Rights
reimbursement front / Ensuring
adequate consent for using samples /
✤ Determining future reimbursement Validation in Clinical Trials:Adaptive
CMS (via Medicare) and states (via trial designs / Codeveloping Rx & Dx
Medicaid) ; private payors
✤ SOX
✤ Informed consent to collection and
testing of samples, authorization of
use/disclosure of data associated with
samples
Some ideas
✤ Online advertising as 100% of our
prospects are online for atleast 3
hours a day
✤ Any of Makrocare’s service can be
bought online?
✤ Is there a POS in Clinical research
Thank you for the
opportunity
Saumitra Rahatekar
03/30/09